[ATX] QoQ Quarter Result on 31-Mar-2023 [#Q4]

Stock
[ATX] Amplia Therapeutics Limited
Announcement Date
30-Mar-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q4]
Profit Trend
QoQ- -14.39%
YoY- -43.45%
Quarter Report
ATX's Result
ATX's Financial Summary
View:
Show?
Quarter Result
30/09/24 31/03/24 30/09/23 31/03/23 30/09/22 31/03/22 30/09/21 CAGR
Revenue 1,407 2,004 2,448 -580 1,769 1,221 763 22.60%
PBT -2,814 -5,364 -3,578 -2,751 -4,640 -3,542 -2,085 10.50%
Tax 0 -1,989 -2,448 580 -1,728 -1,221 -763 -
NP -2,814 -3,374 -1,129 -3,331 -2,912 -2,322 -1,323 28.57%
Tax Rate - - - - - - - -
Total Cost 4,221 5,379 3,578 2,751 4,681 3,542 2,085 26.47%
Ratio Analysis
30/09/24 31/03/24 30/09/23 31/03/23 30/09/22 31/03/22 30/09/21 CAGR
NP Margin -200.02 -168.34 -46.12 574.35 -164.57 -190.17 -173.45 4.86%
Per Share
30/09/24 31/03/24 30/09/23 31/03/23 30/09/22 31/03/22 30/09/21 CAGR
EPS -0.01 -0.02 -0.01 -0.02 -0.01 -0.01 -0.01 0.00%
EPS Diluted -0.01 -0.02 -0.01 -0.02 -0.01 -0.01 -0.01 0.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.